A carregar...

Therapeutic targeting of immune checkpoints with small molecule inhibitors

Immune checkpoints are known to contribute to tumor progression by enhancing cancer’s ability to evade the immune system and metastasize. Immunotherapies, including monoclonal antibodies, have been developed to target specific immunosuppressive molecules on the membranes of cancer cells and have pro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Am J Transl Res
Main Authors: Smith, Wade M, Purvis, Ian J, Bomstad, Colin N, Labak, Collin M, Velpula, Kiran K, Tsung, Andrew J, Regan, Jenna N, Venkataraman, Sujatha, Vibhakar, Rajeev, Asuthkar, Swapna
Formato: Artigo
Idioma:Inglês
Publicado em: e-Century Publishing Corporation 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6413273/
https://ncbi.nlm.nih.gov/pubmed/30899360
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!